Member Info for Tatty99

Kenny 100 do your thing!

Yes that last paragraph about the potential >100,000 tonnes of Sweetbiotix is massive. £3b?

Should PHE be shortly putting out an RNS acknowledging the HUI RNS and comment on any implications for PHE?

This HUI announcement of a reverse takeover will have serious, hopefully positive, implications for PHE, assuming HUI will be using DMG technology.

Interesting to read Aleksandra stating this will lead to the FIRST plastic waste to hydrogen plant being built.

Only 200k shares traded out of 93m. Not evidence of a ‘big seller’

SP drops another 4%

Potential huge market for xf-73 alone subject to phase 3. What’s the delay on phase 3?

Highly regarded CEO with a track record of commercial success

And yet the SP continues to drop towards the last issue price.

Puzzling.

So they have finally formalised that relationship with National Hydrogen who previously stated they were building a DMG plant near Perth. What’s the next step from here?

Big drop today on low volume. Some kind of game going on?

Q4 2024? I hope they’ve got the year right! When will the cash run out?

Apologies if posted before(many posts to wade through!). But I saw that Berenberg Bank issued a report recently rating GGP a BUY with a target of 12p. Nothing too exciting but the right direction. Any other broker forecasts?

The research target is a crumb of comfort assuming it was done thoroughly. The SP may have bottomed out but I'm not sure what and when is the next expected news about XF-73?

Likely heading for last year issue price. May prompt more selling.

They could have/should have released this RNS on Monday.

If there is a big seller selling, they're not stupid. Maybe private shareholders should be selling too?

We all know that start up Pharmas are very high risk and these last 3 days prove it in spades. This is gambling not investing.

Talk about the CEO holding out for a good deal is pure speculation. It may well be that potential big pharma partners would rather remove a rival product before it can be finally approved.

However if XF-73 is all its cracked up to be, one would hope in time this will come good. But that time is likely to be a long way off and likely also to need a lot more funds.

Have fun.

So Equity Development still remain bullish on the future SP. Something weird going on behind the scenes. Who can you trust?

I'm thinking start up Pharmaceutical companies are best avoided until they actually have products to sell.

So far today approx 500,000 shares traded (total buys and sells), is not evidence of a “dump” in my opinion. The RNS is very positive but it would have helped to have a much clearer idea of the next steps towards phase 3 for both versions of XF-73.

Thanks Sajy, and everyone else. I delved into the XF-73 dermal stuff on the Dest website and it mentions NIAID. I thought it may have been mentioned in the list of Clinical Trials on the Niaid website, so still wondering what the position is. Perhaps it doesn't show now the trial has finished. If so, as you say, news due very soon.

Reminders of past statements:

Oct 6th RNS about the TCC manufacturer going bust:

Paul Emmitt, acting CEO of Powerhouse Energy plc, said:

"We are making positive progress at the Centre and look forward to our teams moving in shortly. Whilst frustrating, we do not believe that the TCC and FTU setback is a major concern to PHE and should not delay the scheduled opening of the Technology Centre. We have alternative plans in place which we are optimistic will result in a successful outcome."

Notice no mention of the scheduled building of the FTU.

Nov 6th RNS about the European Patent Challenge

Antony Gardner-Hillman, Chairman of PHE, commented:

"As regards the European Patent Office Communication, I am advised by our patent attorneys there is no significance in this and that it is a normal procedural step when entitlement proceedings have been commenced in respect of a patent.

As regards the proceedings themselves, we do not foresee any impact on PHE's ongoing work or interference with the company's business. We will deal with this as an ordinary day-to-day challenge of a kind I have seen and dealt with successfully before in my career, acting in the appropriate way and with due regard. I do not know the claimant company and I believe its action is intended to "soften" PHE as the targeted party before a follow-on approach on something unrelated. We shall wait and see whether this is the case and we shall respond accordingly. In the meantime, the Company has filed a claim for defence legal costs indemnity under its Intellectual Property insurance policy and is in the process of instructing IP litigation solicitors. Whether or not the Claimant's actions are strategic and for a peripheral purpose, we will be well positioned to respond appropriately.

From the perspective of PHE, I regard these events as just another stage in the journey of a company which is developing and protecting proprietary technology which is sufficiently exciting to attract the attention of others who can see that it holds value."

And Anthony Gardner-Hillman resigned a month later………

Sajy can you please advise what NIAID are actually doing in terms of the awaited results you refer to? I've looked on the NIAID website and can't find any reference to Destiny or XF-73. I'm trying to get an idea where things stand and if its worthy of investing.